Chronic Leukaemia

Retrospective Studies

• CML transplanted in CP2 (Bandini, IT)
  
  
• To look to the outcome of CML patients transplanted in BC (Gratwohl, CH)
  
  
• Cord blood transplantations in CML (Sanz, ES)
  
  
• Investigation of donor age and donor age effects (Niederwieser, DE)
  
  
• Role of CD34+ cell dose on outcome in HLA identical sibling transplants for CML a. urbano ispizua
  
  
• comparison of ATG-fresenius and lymphoglobulin-Genzyme during conditioning for unrelated transplants in chronic phase in CML (M. Schleuning, DE)
  
  
• retrospective analysis of several factors of possible influence on the results and outcome of DLI as treatment for CML relapse post allo transplant (Schmid, DE)
  
  
• DLI in molecular relapse of CML (A.Urbano-Ispizua, ES)
  
  
• Myelosuppression after DLI (A.Urbano-Ispizua, ES)
  
  
• We aim to analyse the efficacy and toxicity of dli given after reduced-intensity conditioning in allogeneic transplants for cml (T. Ruutu/K. Porkka)
  
  
• To analyse the incidence and severity of agvhd and cgvhd post DLI in relapsed CML patients as well as factors related with outcome of gvhd yves chalandon
  
  
• CLWP retro study of initial cell dose of DLI in CML relapse patients in unrelated transplantations (Hertenstein, Guglielmi)
  
  
• DLI in patients with relapse after VUD-SCT for CML (A. Schattenberg, NL)
  
  
• To evaluate indications, techniques and outcome for transplants performed to treat Chronic Prolymphocytic Leukemia (W. Wiktor-Jedrzejczak, PL)
  
  
• Investigation the outcome of children with MDS/sAML (Locatelli, IT)
  
  
• 2nd Transplant / DLI after relapse in allo MDS/sAML (Greinix, AT)
  
  
• MDS after SAA (cooperation with SAA registry) (Locatelli, IT)
  
  
• autologous transplants in MDS/sAL => repopulation after transplant (Delforge, BE)
  
  
• investigation of HES (Arnon Nagler, IL)
  
  
• To evaluate allo-transplant results in essential or primary (Phi.negative) thrombocythemia (A.Nagler, IL)
  
  
• Impact of CMML subclassification (dysplastic vs prolif) and type of conditioning (standard vs reduced) on outcome in allo SCT patients with CMML (A. Symeonidis, GR)
  
  
• MUD SCT improved results in MDS/sAL (P. Guardiola)
  
  
• Polycythaemia Vera (A. Rambaldi, IT)
  
  
• An update of allogeneic PBSCT versus BMT in MM (G. Gahrton, SE)
  
  
• TTP after stem cell transplantation (Fijnheer)
  
  
• Inventory of HC after transplants in the last years (Berndt Hertenstein, DE)
  
  
• To investigate the incidence of Capillary Leak Syndrome, to define parameters with influence on CLS, to evaluate basic data for a prospective study (Michael Kiehl, DE)
  
  
• Graft failure after reduced intensity conditioning (B. Hertenstein, DE)

For the complete address of contact people, please consult the membership list